Overview
Lyme disease is a tick-transmitted zoonosis. It is the most widespread vector-borne disease in the whole of the northern hemisphere. Its incidence continues to rise at global level due to myriad demographic and environmental factors, including climate change.
The real-time PCR based TaqPath Menu™ GeneProof™ Borrelia PCR Kit helps the qualitative detection of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, B. andersonii, B. bissettii, B. valaisiana, B. lusitaniae, B. japonica, B. tanukii, B. turdi, B. sinica, B. mayonii, B. spielmanii, B. bavariensis, B. kurtenbachii, B. miyamotoi (Asian genotype) in CSF, plasma, serum, tick, urine, and whole blood (EDTA).
Product portfolio
High sensitivity
- Secured by targeting the multicopy sequence of the 16S rRNA gene
- 100% diagnostic sensitivity
Easy-to-use concept
- Single tube ready-to-use Master Mix contains all components for PCR amplification
- No additional pipetting of PCR reagents is necessary
Contamination reduction
- Master Mix contains uracil-DNA glycosylase (UNG) and dUTPs reducing carryover contamination
High specificity
- 15 Borrelia burgdorferi sensu lato strains worldwide
- Borrelia burgdorferi sensu stricto
- Borrelia miyamotoi
Compatible with a wide range of real-time PCR devices
CE-marked kit
Want to use our solutions? Contact us for details on our limited time offer. |
Ordering information
For In Vitro Diagnostic Use.
Intended use and regulatory statements of products vary. For specific intended use and regulatory statements, please refer to the Instructions for Use (IFU).
Product availability by country varies. For product availability in your country, check the associated product webpages. TaqPath™ Menu | GeneProof™ assays are manufactured by GeneProof™ and distributed by Thermo Fisher Scientific.
© 2023 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. GeneProof is a trademark of GeneProof a.s.